Fortune via AOL
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs
6 days ago
Investor's Business Daily
Novo Nordisk Dips After Wegovy Sales Double, But Miss Analysts' Forecast
Simply Wall St. via Yahoo Finance
Shareholders in Growthpoint Properties (JSE:GRT) are in the red if they invested five years ago
15 minutes ago
Eurocell (LON:ECEL) shareholders have endured a 42% loss from investing in the stock three years ago
21 hours ago
Shareholders in Clarivate (NYSE:CLVT) are in the red if they invested three years ago
19 hours ago
Indianapolis Business Journal
Obesity drug rivals aim to unseat Zepbound, Ozempic - Indianapolis Business Journal
Scripps News via AOL
Swifties, BBLs and Ozempic: What is Drake and Kendrick Lamar's feud even about?
6 hours ago
Investing in MMAG Holdings Berhad (KLSE:MMAG) a year ago would have delivered you a 95% gain
34 minutes ago
Investopedia
Amgen Stock Surges After Q1 Earnings Beat, 'Encouraging' Weight-Loss Drug Update
7 days ago
Fortune
Best Nutrition Apps of 2024 | Fortune Recommends Health